Literature DB >> 12076695

Tenascin and beta 6 integrin are overexpressed in floor of mouth in situ carcinomas and invasive squamous cell carcinomas.

Joseph A Regezi1, Daniel M Ramos, Robert Pytela, Nusi P Dekker, Richard C K Jordan.   

Abstract

Floor of the mouth squamous cell carcinomas exhibit many characteristics that suggest they represent a distinct biological subset within head and neck tumors. The features of preinvasive lateral intraepithelial spread, high rate of conversion of intraepithelial neoplasia to invasive carcinoma, and high incidence of occult metastases, suggest the importance of motility-associated proteins in the pathogenesis of these lesions. Two such proteins, tenascin and beta 6 integrin, are generally overexpressed in squamous carcinomas, and may play a central role in the invasive process of floor of the mouth lesions. The purpose of this study was to evaluate in situ and invasive squamous cell carcinomas from the floor of the mouth for the expression of tenascin and beta 6 integrin. Twenty lesions each of floor of the mouth in situ carcinomas and squamous cell carcinomas, and 10 normal controls were stained for tenascin and beta 6 using a standard immunohistochemical protocol for formalin-fixed specimens. Sections were assessed for staining intensity, pattern, and co-localization. Tenascin was highly expressed at the keratinocyte-connective tissue interface of both in situ and invasive carcinomas. beta 6 was expressed in basal keratinocytes of all in situ and invasive lesions, but was not evident in any of the control epithelia. There was no significant difference in staining of in situ and invasive carcinomas, but there was a significant difference in staining between these lesions and controls. Staining was colocalized in serial sections, supporting a receptor-ligand relationship. Both tenascin and beta 6 were weakly expressed in dysplastic areas adjacent to carcinomas suggesting that changes in the expression of these proteins occurs prior to the invasive phenotype. We conclude that tenascin and beta 6 are overexpressed in in situ and invasive floor of the mouth carcinomas, but that transgression of the basement membrane by neoplastic epithelial cells requires additional changes to the keratinocyte molecular profile.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12076695     DOI: 10.1016/s1368-8375(01)00062-8

Source DB:  PubMed          Journal:  Oral Oncol        ISSN: 1368-8375            Impact factor:   5.337


  24 in total

1.  Single-nucleotide polymorphisms of integrins are associated with the risk and lymph node metastasis of oral squamous cell carcinoma.

Authors:  Xiang-Rui Ma; Hui Cheng; Xiao-Yi Wang; Hao Liu; Dan Zhao
Journal:  Med Oncol       Date:  2012-01-21       Impact factor: 3.064

2.  High-molecular tenascin-C as an indicator of atypical cells in oral brush biopsies.

Authors:  O Driemel; R Dahse; A Berndt; H Pistner; S G Hakim; L Zardi; T E Reichert; H Kosmehl
Journal:  Clin Oral Investig       Date:  2006-11-17       Impact factor: 3.573

Review 3.  [Oral cytology: historical development, current status, and perspectives].

Authors:  M Hullmann; T E Reichert; R Dahse; F von Eggeling; H Pistner; H Kosmehl; O Driemel
Journal:  Mund Kiefer Gesichtschir       Date:  2007-01

4.  Complex formation of the laminin-5 gamma2 chain and large unspliced tenascin-C in oral squamous cell carcinoma in vitro and in situ: implications for sequential modulation of extracellular matrix in the invasive tumor front.

Authors:  Marcus Franz; Torsten Hansen; Petra Richter; Laura Borsi; Frank-D Böhmer; Peter Hyckel; Peter Schleier; Detlef Katenkamp; Luciano Zardi; Hartwig Kosmehl; Alexander Berndt
Journal:  Histochem Cell Biol       Date:  2005-12-13       Impact factor: 4.304

Review 5.  Molecular imaging of integrin αvβ6 expression in living subjects.

Authors:  Hao Liu; Yue Wu; Fan Wang; Zhaofei Liu
Journal:  Am J Nucl Med Mol Imaging       Date:  2014-06-07

6.  Synthesis and biological evaluation of a peptide-paclitaxel conjugate which targets the integrin αvβ₆.

Authors:  Shunzi Li; Bethany Powell Gray; Michael J McGuire; Kathlynn C Brown
Journal:  Bioorg Med Chem       Date:  2011-08-04       Impact factor: 3.641

7.  Transcriptional activation of integrin beta6 during the epithelial-mesenchymal transition defines a novel prognostic indicator of aggressive colon carcinoma.

Authors:  Richard C Bates; David I Bellovin; Courtney Brown; Elizabeth Maynard; Bingyan Wu; Hisaaki Kawakatsu; Dean Sheppard; Peter Oettgen; Arthur M Mercurio
Journal:  J Clin Invest       Date:  2005-02       Impact factor: 14.808

8.  Prognostic significance of tenascin-C expression in superficial and invasive bladder cancer.

Authors:  A Brunner; C Mayerl; A Tzankov; I Verdorfer; I Tschörner; H Rogatsch; G Mikuz
Journal:  J Clin Pathol       Date:  2004-09       Impact factor: 3.411

9.  Clinical significance of integrin αvβ6 expression effects on gastric carcinoma invasiveness and progression via cancer-associated fibroblasts.

Authors:  Zhuonan Zhuang; Ruiling Zhou; Xiaozhou Xu; Tian Tian; Yi Liu; Yanfeng Liu; Peilong Lian; Jiayong Wang; Kesen Xu
Journal:  Med Oncol       Date:  2013-05-15       Impact factor: 3.064

10.  Epithelial-to-mesenchymal transition in the development and progression of adenocarcinoma and squamous cell carcinoma of the lung.

Authors:  Ludmila Prudkin; Diane D Liu; Natalie C Ozburn; Menghong Sun; Carmen Behrens; Ximing Tang; Kathlynn C Brown; B Nebiyou Bekele; Cesar Moran; Ignacio I Wistuba
Journal:  Mod Pathol       Date:  2009-03-06       Impact factor: 7.842

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.